High permeability of dialysis membranes: what is the limit of albumin loss?
Open Access
- 1 April 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 18 (4) , 651-654
- https://doi.org/10.1093/ndt/gfg054
Abstract
The enhanced removal of an extended spectrum of toxic low molecular weight proteins is regarded as a contribution to the improvement of dialysis adequacy. Apart from costly convective treatment modalities like haemofiltration and haemodiafiltration, the application of high‐flux haemodialysis permits the elimination of far larger uraemic toxins than those removable by conventional low‐flux dialysis. As a consequence, increasingly permeable high‐flux dialysis membranes with excellent blood purification characteristics have been developed during the last decade, contributing to clinical benefits such as an improved erythropoietin responsiveness in renal anaemia [1,2]. However, the membrane pore size can be enlarged only within restricted limits, since together with the removal of high molecular weight toxins such as, for instance, erythropoietic inhibitors [3], essential large proteins such as albumin get lost, eventually resulting in a deficiency state.Keywords
This publication has 35 references indexed in Scilit:
- Author Index Vol. 12, 2001Cerebrovascular Diseases, 2001
- The modality of dialysis treatment: does it influence the response to erythropoietin treatment?Nephrology Dialysis Transplantation, 2001
- Filtration of native and glycated β2-microglobulin by charged and neutral dialysis membranesKidney International, 2001
- Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patientsKidney International, 2001
- Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykininKidney International, 1998
- Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysisKidney International, 1995
- Mechanisms of hypoalbuminemia in hemodialysis patientsKidney International, 1995
- Dialysate protein losses with bleach processed polysulphone dialyzersKidney International, 1995
- Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysisKidney International, 1984